Turk Ilac ve Serum Sanayi AS (TRILC) — Cash Flow-to-Debt Ratio
Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of TL44.50 Million could theoretically repay 0% of its total liabilities (TL4.21 Billion) in one year. See Turk Ilac ve Serum Sanayi AS leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Turk Ilac ve Serum Sanayi AS Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Turk Ilac ve Serum Sanayi AS across 7 annual periods. For the full cash flow conversion analysis, see TRILC operating cash flow.
Annual Cash Flow-to-Debt Ratio for Turk Ilac ve Serum Sanayi AS (2018–2024)
Year-by-year debt coverage analysis for Turk Ilac ve Serum Sanayi AS. Check how high is Turk Ilac ve Serum Sanayi AS's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.18x | TL-378.48 Million | TL2.07 Billion | ▼ -146.8% |
| 2023 | 0.39x | TL408.19 Million | TL1.04 Billion | ▲ +1678.4% |
| 2022 | -0.02x | TL-11.88 Million | TL479.65 Million | ▲ +89.8% |
| 2021 | -0.24x | TL-71.67 Million | TL295.46 Million | ▼ -283.4% |
| 2020 | 0.13x | TL33.20 Million | TL250.99 Million | ▲ +100.5% |
| 2019 | 0.07x | TL13.32 Million | TL201.84 Million | ▼ -78.0% |
| 2018 | 0.30x | TL38.13 Million | TL127.38 Million | — |